Kaposi's sarcoma: A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
C3_KAPOSI_SARCOMA
Extra metadata
List of similar endpoints to
Kaposi sarcoma
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 24 | - | 19 |
| Unadjusted prevalence (%) | 0.01 | - | 0.02 |
| Mean age at first event (years) | 63.15 | - | 62.19 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | - | - | - | - |
| 15 years | - | - | - | - |
| 5 years | - | - | - | - |
| 1 year | - | - | - | - |
Index endpoint: C3_KAPOSI_SARCOMA – Kaposi sarcoma
GWS hits:
before Kaposi sarcoma
after Kaposi sarcoma
Loading survival analyses plot
Loading survival analyses table
